Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine levels

NeuroToxicology

Volumn 44, Issue , 2014, Pages 48-57

  El Naga, Reem N ^a   Ahmed, Hebatalla I ^b   Abd Al Haleem, Ekram N ^b  

^a Ain Shams University   (Egypt)

^b Cairo University   (Egypt)

Author keywords

Depression; Indole 3 carbinol; Inflammation; Monoamine; Oxidative stress

Indexed keywords

3 INDOLEMETHANOL; CLONIDINE; FLUOXETINE; GLUTATHIONE; MONOAMINE; NEURON SPECIFIC ENOLASE; NORADRENALIN; SEROTONIN; SUPEROXIDE DISMUTASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOGENIC AMINE; ENOLASE; INDOLE DERIVATIVE; INDOLE-3-CARBINOL; NEUROPROTECTIVE AGENT;

ANIMAL BEHAVIOR; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BEHAVIOR CHANGE; BRAIN LEVEL; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; FORCED SWIM TEST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; MALE; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; RAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BIOGENIC MONOAMINES; BRAIN; CLONIDINE; DEPRESSION; INDOLES; INFLAMMATION; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHOSPHOPYRUVATE HYDRATASE; RATS;

RATTUS;

EID: 84901984505     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.05.004     Document Type: Article

References (57)

1. Abou El Naga R.N., Azab S.S., El-Demerdash E., Shaarawy S., El-Merzabani M., Ammar el-S.M. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sci 2013, 92:555-561.
2. Aggarwal B.B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397-1421.
3. Banchroft J.D., Stevens A., Turner D.R. Theory and practice of histological techniques 1996, Churchil Livingstone, New York/London/San Francisco/Tokyo. Fourth ed.
4. Bilici M., Efe H., Köroǧlu M.A., Uydu H.A., Bekaroǧlu M., Deǧer O. Antioxidative enzyme activities and lipid peroxidation in major depression:alterations by antidepressant treatments. J Affect Disord 2001, 64(1):43-51.
5. Bradford M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
6. Bronikowski A.M., Carter P.A., Swallow J.G., Girard I.A., Rhodes J.S., Garland T. Open-field behavior of house mice selectively bred for high voluntary wheel-running. Behav Genet 2001, 31(3):309-316.
7. Byerley W.F., Risch S.C. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment. J Clin Psychopharmacol 1985, 5:191-206.
8. Capasso A., Di Giannuario A., Loizzo A., Pieretti S., Sorrentino L. Dexamethasone modifies the behavioral effects induced by clonidine in mice. Gen Pharmacol 1996, 27:1429-1434.
9. Catena-Dell'Osso M., Bellantuono C., Consoli G., Baroni S., Rotella F., Marazziti D. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?. Curr Med Chem 2011, 18:245-255.
10. Cunha J.M., Masur J. Evaluation of psychotropic drugs with a modified open field test. Pharmacology 1978, 16:259-267.
11. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
12. El-Shinnawy N.A., Abd-Elmageid S.A., Alshailabi E.M. Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcerin rats. Toxicol Ind Health 2014, 30(4):357-375.
13. Enginar N., Eroglu L. The long-term clonidine treatment induced behavioral depression in rats. Pol J Pharmacol Pharm 1990, 42:409-415.
14. Iwasaki E., Takasugi Y., Koga Y. Alteration of neurotransmitters in the cerebrospinal fluid in SHRSP rats due to long-term administration of clonidine. Masui 2006, 55:330-337.
15. Jeong Y.-M., Li H., Kim S.Y., Yun H.Y., Baek K.J., Kwon N.S., et al. Indole-3-carbinol inhibits prostate cancer cell migration via degradation of beta-catenin. Oncol Res 2011, 19:237-243.
16. Jiang J., Kang T.B., Shim W., Oh N.H., Kim T.J., Lee K.H. Indole-3-carbinol inhibits LPS-induced inflammatory response by blocking TRIF-dependent signaling pathway in macrophages. Food Chem Toxicol 2013, 57:256-261.
17. Jindal A., Mahesh R., Bhatt S. Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage. Pharmacol Biochem Behav 2013, 105:63-70.
18. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981, 5(2):247-251.
19. Kreisel T., Frank M.G., Licht T., Reshef R., Ben-Menachem-Zidon O., Baratta M.V., et al. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Phys 2014, 19(6):699-709.
20. Kulikov A.V., Morozova M.V., Kulikov V.A., Kirichuk V.S., Popova N.K. Automated analysis of antidepressants' effect in the forced swim test. J Neurosci Methods 2010, 191:26-31.
21. Kulkarni S., Dhir A., Akula K.K. Potentials of curcumin as an antidepressant. Sci World J 2009, 9:1233-1241.
22. Lang U.E., Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 2013, 31:761-777.
23. Li Y., Kong D., Ahmad A., Bao B., Sarkar F.H. Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?. Antioxid Redox Signal 2013, 19:139-150.
24. Lopresti A.L., Hood S.D., Drummond P.D. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. J Psychopharmacol 2012, 26:1512-1524.
25. Lucca G., Comim C.M., Valvassori S.S., Réus G.Z., Vuolo F., Petronilho F., et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int 2009, 54:358-362.
26. Maes M., Meltzer H.Y., Scharpé S., Cooreman W., Uyttenbroeck W., Suy E., et al. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res 1993, 47(3):229-241.
27. Maes M., Song C., Yirmiya R. Targeting IL-1 in depression. Expert Opin Ther Targets 2012, 16:1097-1112.
28. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
29. Makhija K., Karunakaran S. The role of inflammatory cytokines on the aetiopathogenesis of depression. Aust N Z J Psychiatry 2013, 47(9):828-839.
30. Marconett C.N., Sundar S.N., Tseng M., Tin A.S., Tran K.Q., Mahuron K.M., et al. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. Carcinogen 2011, 32(9):1315-1323.
31. Miczek K.A., Fish E.W., De Bold J.F., De Almeida R.M. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacol 2002, 163:434-458.
32. Mihara M., Uchiyama M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978, 86:271-278.
33. Moretti M., Budni J., Dos Santos D.B., Antunes A., Daufenbach J.F., Manosso L.M., et al. Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice. J Mol Neurosci 2013, 49(1):68-79.
34. Nelson R.J., Trainor B.C. Neural mechanisms of aggression. Nat Rev Neurosci 2007, 8:536-546.
35. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psych Res 2007, 41:189-206.
36. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008, 11(6):851-876.
37. Ortmann R., Mutter M., Delini-Stula A. Effect of yohimbine and its diastereoisomers on clonidine-induced depression of exploration in the rat. Eur J Pharmacol 1982, 77:335-377.
38. Parale M.P., Kulkarni S.K. Clonidine - induced behavioural despair in mice: reversal by antidepressants. Psychopharmacol (Berl) 1986, 89:171-174.
39. Parkin D.R., Malejka-Giganti D. Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol. Cancer Detect Prev 2004, 28:72-79.
40. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229(2):327-336.
41. Prasad A., Shotliff K. Depression and chronic clonidine therapy. Postgrad Med J 1993, 69:327-328.
42. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55(5):453-462.
43. Rawdin B.J., Mellon S.H., Dhabhar F.S., Epel E.S., Puterman E., Su Y., et al. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 2013, 31:143-152.
44. Reynolds J.L., Ignatowski T.A., Sud R., Spengler R.N. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience 2005, 133:519-531.
45. Rostoka E., Isajevs S., Baumane L., Line A., Silina K., Dzintare M., et al. Effects of lycopene, indole-3-carbinol, and luteolin on nitric oxide production and iNOS expression are organ-specific in rats. Arh Hig Rada Toksikol 2010, 61:275-285.
46. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007, 22:67-73.
47. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. J Neuropsychiatry Clin Neurosci 1965, 7:524-533.
48. Sen S., Jaiswal A.K., Yanpallewar S., Acharya S.B. Anxiogenic potential of ciprofloxacin and norfloxacin in rats. Singapore Med J 2007, 48:1028-1032.
49. Shelton R., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D., et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011, 16:751-762.
50. Srivastava S.K., Nath C. The differential effects of calcium channel blockers in the behavioural despair test in mice. Pharmacol Res 2000, 42(4):293-297.
51. Streitbürger D.P., Arelin K., Kratzsch J., Thiery J., Steiner J., Villringer A., et al. Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combinedserum, gene expression and MRI study. PLoS ONE 2012, 7(8):e43284.
52. Waiskopf N., Ofek K., Gilboa-Geffen A., Bekenstein U., Bahat A., Bennett E.R., et al. AChE and RACK1 promote the anti-inflammatory properties of fluoxetine. J Mol Neurosci 2013, [in press].
53. Walker A.K., Rivera P.D., Wang Q., Chuang J.C., Tran S., Osborne-Lawrence S., et al. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Mol Psychiatry 2014, [in press].
54. Wiener C.D., Jansen K., Ghisleni G., Kaster M.P., Souza L.D., Lara D.R., et al. Reduced serum levels of neuron specific enolase (NSE) in drug-naïve subjects with major depression and bipolar disorder. Neurochem Res 2013, 38(7):1394-1398.
55. Wu T.Y., Saw C.L., Khor T.O., Pung D., Boyanapalli S.S., Kong A.N. In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf2 and cell cycle/apoptosis signaling pathways. Mol Carcinog 2012, 51:761-770.
56. Yi L.T., Li C.F., Zhan X., Cui C.C., Xiao F., Zhou L.P., et al. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1223-1228.
57. Zafir A., Ara A., Banu N. In vivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(2):220-228.